首页 > 最新文献

Nepalese Heart Journal最新文献

英文 中文
Twenty-five years of Cardiac Surgery in Nepal: Trials, Tribulations and Triumph 25年的尼泊尔心脏手术:考验、磨难和胜利
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48936
Bijoy G Rajbanshi, S. Pradhan, B. Koirala
Twenty-five years ago, embarked the start of the era of cardiovascular surgery using the heart lung machine in the country and as we celebrate this humble beginning, we sought to review the advent and the progress made in this field of science over the course of the years in the country; delve in to the challenges and opportunities that it may present in the future to uphold this great profession.
25年前,我国开始了使用心肺机进行心血管手术的时代,在我们庆祝这一卑微的开端之际,我们试图回顾我国多年来在这一科学领域的出现和取得的进展;深入研究未来维护这一伟大职业可能带来的挑战和机遇。
{"title":"Twenty-five years of Cardiac Surgery in Nepal: Trials, Tribulations and Triumph","authors":"Bijoy G Rajbanshi, S. Pradhan, B. Koirala","doi":"10.3126/njh.v20i2.48936","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48936","url":null,"abstract":"Twenty-five years ago, embarked the start of the era of cardiovascular surgery using the heart lung machine in the country and as we celebrate this humble beginning, we sought to review the advent and the progress made in this field of science over the course of the years in the country; delve in to the challenges and opportunities that it may present in the future to uphold this great profession.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45724604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of Clinical Profiles, Risk Factors and Coronary Angiographic Patterns in Female Patients Presenting with Anginal Chest Pain in a Tertiary Care Centre of Nepal 尼泊尔一家三级医疗中心女性心绞痛患者的临床特征、危险因素和冠状动脉造影模式研究
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48868
S. Adhikari, R. Gajurel, C. Poudel, H. Shrestha, S. Thapa, S. Devkota, B. Manandhar, R. Khanal, S. Shakya, V. Yadav, Manju Sharma, Ravi Sahi, Jeevan Thapa
Background and Aims: Coronary artery disease is one of the important causes of deaths in females in many countries. Females with chest pain are more likely to be treated in a different way as compared to males at the time of presentation. Worldwide, there has been a considerable rise in the number of females who are undergoing coronary angiography recently. Methods: This study was a single-centre, prospective, observational study conducted in the department of cardiology, MCVTC, Tribhuvan University, Nepal. The study period was from 5th  July 2020 to  4th July 2021.155 female patients with anginal chest pain were enrolled. Data were collected after thorough history taking, physical examination, laboratory investigations, and coronary angiography. They were further divided into three age groups:<50 years,50-65 years and >65 years. Subsequently statistical analysis was done using latest version of SPSS. Results: The mean age of the patients was 59.64 years (SD=11.428). There were 119 (76.77%) postmenopausal patients. The most prevalent risk factor of IHD  was HTN (43.87% ). Obesity/overweight was most common (58.62%) in those with age <50 years. DM was most common (26.32%) in age group 50-65 years. HTN was the most prevalent (52.63%) in age group 50-65 years. The maximum proportion of dyslipidemic patients (34.21%) were found in age group 50-65 years. 52.25% patients presented with acute coronary syndrome. 33.55% patients had normal coronary arteries. 11.61% patients had nonobstructive coronary artery disease. Obstructive coronary artery disease was found in 51.61% patients. IN patients with obstructive CAD, LAD was the most commonly involved vessel followed by RCA . Conclusion: Findings from our study shows higher prevalence of risk factors for IHD in Nepalese females. This study also demonstrates that as females get older and become postmenopausal, the number of risk factors for CAD increases. Understanding the risk factors for CAD and angiographic patterns in females could be helpful in implementing optimal treatment strategies in females with angina.
背景和目的:冠状动脉疾病是许多国家女性死亡的重要原因之一。与男性相比,患有胸痛的女性在出现胸痛时更有可能以不同的方式接受治疗。在全球范围内,最近接受冠状动脉造影的女性人数有了相当大的增长。方法:本研究是一项在尼泊尔特里布万大学MCVTC心脏病学系进行的单中心前瞻性观察性研究。研究期间为2020年7月5日至2021年7月4日。共有55名女性心绞痛患者入选。在全面的病史采集、体格检查、实验室调查和冠状动脉造影后收集数据。他们被进一步分为三个年龄组:65岁。随后使用最新版本的SPSS进行统计分析。结果:患者平均年龄59.64岁(SD=11.428),绝经后患者119例(76.77%)。IHD最常见的危险因素是HTN(43.87%)。肥胖/超重在年龄<50岁的人群中最为常见(58.62%)。糖尿病在50-65岁年龄组最常见(26.32%)。HTN在50-65岁年龄组中最为普遍(52.63%)。血脂异常患者的比例最大(34.21%)发生在50-65岁的年龄组。52.25%的患者出现急性冠状动脉综合征。33.55%的患者冠状动脉正常。11.61%的患者有非阻塞性冠状动脉疾病。51.61%的患者患有阻塞性冠状动脉疾病。在梗阻性CAD患者中,LAD是最常见的受累血管,其次是RCA。结论:我们的研究结果表明,尼泊尔女性IHD的危险因素患病率较高。这项研究还表明,随着女性年龄的增长和绝经后,CAD的风险因素数量会增加。了解女性冠心病的危险因素和血管造影模式可能有助于实施女性心绞痛的最佳治疗策略。
{"title":"Study of Clinical Profiles, Risk Factors and Coronary Angiographic Patterns in Female Patients Presenting with Anginal Chest Pain in a Tertiary Care Centre of Nepal","authors":"S. Adhikari, R. Gajurel, C. Poudel, H. Shrestha, S. Thapa, S. Devkota, B. Manandhar, R. Khanal, S. Shakya, V. Yadav, Manju Sharma, Ravi Sahi, Jeevan Thapa","doi":"10.3126/njh.v20i2.48868","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48868","url":null,"abstract":"Background and Aims: Coronary artery disease is one of the important causes of deaths in females in many countries. Females with chest pain are more likely to be treated in a different way as compared to males at the time of presentation. Worldwide, there has been a considerable rise in the number of females who are undergoing coronary angiography recently. \u0000Methods: This study was a single-centre, prospective, observational study conducted in the department of cardiology, MCVTC, Tribhuvan University, Nepal. The study period was from 5th  July 2020 to  4th July 2021.155 female patients with anginal chest pain were enrolled. Data were collected after thorough history taking, physical examination, laboratory investigations, and coronary angiography. They were further divided into three age groups:<50 years,50-65 years and >65 years. Subsequently statistical analysis was done using latest version of SPSS. \u0000Results: The mean age of the patients was 59.64 years (SD=11.428). There were 119 (76.77%) postmenopausal patients. The most prevalent risk factor of IHD  was HTN (43.87% ). Obesity/overweight was most common (58.62%) in those with age <50 years. DM was most common (26.32%) in age group 50-65 years. HTN was the most prevalent (52.63%) in age group 50-65 years. The maximum proportion of dyslipidemic patients (34.21%) were found in age group 50-65 years. 52.25% patients presented with acute coronary syndrome. 33.55% patients had normal coronary arteries. 11.61% patients had nonobstructive coronary artery disease. \u0000Obstructive coronary artery disease was found in 51.61% patients. IN patients with obstructive CAD, LAD was the most commonly involved vessel followed by RCA . \u0000Conclusion: Findings from our study shows higher prevalence of risk factors for IHD in Nepalese females. This study also demonstrates that as females get older and become postmenopausal, the number of risk factors for CAD increases. Understanding the risk factors for CAD and angiographic patterns in females could be helpful in implementing optimal treatment strategies in females with angina.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49647732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Correlation between Left main artery diameter derived by Finet’s Law and direct angiographic quantitative coronary dimension analysis Finet定律导出的左主动脉直径与直接血管造影定量冠状动脉尺寸分析的相关性
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48932
K. Shaha, Ashok Adhikari, Sajjad Safi, Avisesh Shakya, Sanjay Shrestha
Background and Aims: In the era of left main angioplasty, the aim of this study is to evaluate the applicability of Finet’s law in left main diameter calculation and establish this as a useful feasible alternative  tool to intravascular ultrasound  in the left main intervention. Methods: A total of 164 patients who underwent coronary angiography at PAHS  due to suspicion of coronary artery disease between 1st January 2017 and April 2020 were included. The left main diameter(do-QCA) was calculated using the Quantitative coronary angiographic (QCA) method and correlated with the Left main diameter (do-finets) derived from Finet’s law which takes into account the diameter (d1) of the proximal left anterior descending artery (LAD) and left  circumflex (LCX) diameter (d2) derived from QCA, added together and multiplied by the factor of 0.678 i.e do-finets=0.678(d1+d2). Results: Using the Bivariate Pearson correlation method, do-QCA was found to have a positive correlation with do-finets with a correlation coefficient of (r=0.721) significant at the level of P value 0.01 (2-tailed). Conclusion: The application of Finet’s Law using the QCA method has been found to be a handy feasible alternative tool to intravascular ultrasound   in calculating the left main diameter for the left main intervention where intravascular ultrasound  is not available or economic constraint prevails.
背景和目的:在左主干血管成形术时代,本研究的目的是评估Finet定律在左主干直径计算中的适用性,并将其作为血管内超声在左主干介入治疗中的一种有用可行的替代工具。方法:纳入2017年1月1日至2020年4月期间因疑似冠状动脉疾病而在PAHS接受冠状动脉造影的164名患者。使用定量冠状动脉造影(QCA)方法计算左主干直径(do QCA),并将其与从Finet定律导出的左主干直径相关联,Finet定律考虑了近端左前降支(LAD)的直径(d1)和从QCA导出的左旋支(LCX)直径(d2),结果:采用双变量Pearson相关方法,do-QCA与do finets呈正相关,相关系数为(r=0.721),在P值0.01(2-尾)的水平上显著。结论:在血管内超声不可用或存在经济限制的情况下,使用QCA方法应用Finet定律是血管内超声计算左主干介入治疗左主干直径的一种方便可行的替代工具。
{"title":"Correlation between Left main artery diameter derived by Finet’s Law and direct angiographic quantitative coronary dimension analysis","authors":"K. Shaha, Ashok Adhikari, Sajjad Safi, Avisesh Shakya, Sanjay Shrestha","doi":"10.3126/njh.v20i2.48932","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48932","url":null,"abstract":"Background and Aims: In the era of left main angioplasty, the aim of this study is to evaluate the applicability of Finet’s law in left main diameter calculation and establish this as a useful feasible alternative  tool to intravascular ultrasound  in the left main intervention. \u0000Methods: A total of 164 patients who underwent coronary angiography at PAHS  due to suspicion of coronary artery disease between 1st January 2017 and April 2020 were included. The left main diameter(do-QCA) was calculated using the Quantitative coronary angiographic (QCA) method and correlated with the Left main diameter (do-finets) derived from Finet’s law which takes into account the diameter (d1) of the proximal left anterior descending artery (LAD) and left  circumflex (LCX) diameter (d2) derived from QCA, added together and multiplied by the factor of 0.678 i.e do-finets=0.678(d1+d2). \u0000Results: Using the Bivariate Pearson correlation method, do-QCA was found to have a positive correlation with do-finets with a correlation coefficient of (r=0.721) significant at the level of P value 0.01 (2-tailed). \u0000Conclusion: The application of Finet’s Law using the QCA method has been found to be a handy feasible alternative tool to intravascular ultrasound   in calculating the left main diameter for the left main intervention where intravascular ultrasound  is not available or economic constraint prevails.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44924366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Angiography and Percutaneous coronary Intervention in Anomalous Origin of Right Coronary Artery Arising from the Left Sinus of Valsalva 左窦右冠状动脉起源异常的冠状动脉造影及经皮冠状动脉介入治疗
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48952
C. Poudel, R. Gajurel, H. Shrestha, S. Devkota, S. Thapa, R. Khanal, S. Shakya, B. Manandhar, V. Yadav
Background and Aims: To assess the difficulties encountered while performing coronary angiography and percutaneous coronary intervention in anomalous right coronary artery arising from the left sinus of Valsalva. Methods: Between January 2016 and December 2020, a total of 23 patients underwent coronary angiography and eight underwent percutaneous coronary intervention for an angiographic significant lesion in the anomalous right coronary artery arising from the left sinus of Valsalva. The vascular approach, usage of catheters, fluoroscopic time, and the amount of contrast used were also assessed. Results: Among 6000 coronary angiography and 1500 percutaneous coronary intervention performed, 33 patients (0.55%) had right coronary artery arising from the left sinus of Valsalva. Altogether, 14 patients had type-A, seven had Type-B, eight had Type-C, and four had Type-D anomalous right coronary artery arising from the left sinus of Valsalva. Coronary Angiography was accomplished with the Tiger catheter in 13 patients, Judkins left JL in 8 patients, and Extra-backup (XB3) in one patient. In the percutaneous coronary intervention group, cannulation was done with Judkins left (JL), Amplatz left (AL), and XB in five, two, and one patient respectively and among five type-A patients, four were cannulated with JL and one with XB; one Type-B with JL4; and two Type-C with AL2. The mean fluoroscopic time and contrast volume consumption for coronary angiography and percutaneous coronary intervention were 9.9 minutes and 47 minutes respectively and 63ml and 229 ml respectively. Conclusion: Coronary intervention of anomalous right coronary artery arising from the left sinus of Valsalva is difficult due to inappropriate selection of guide catheter and is associated with a higher both mean fluoroscopic time and contrast volume. Radial route is equally effective for successful procedure.
背景和目的:评估左瓦尔萨尔瓦窦异常右冠状动脉在进行冠状动脉造影和经皮冠状动脉介入治疗时遇到的困难。方法:2016年1月至2020年12月,共有23名患者接受了冠状动脉造影,8名患者因左瓦尔萨尔瓦窦右冠状动脉异常病变接受了经皮冠状动脉介入治疗。还评估了血管入路、导管的使用、荧光透视时间和使用的对比度。结果:在6000例冠状动脉造影和1500例经皮冠状动脉介入治疗中,33例(0.55%)患者的右冠状动脉起源于左瓦尔萨尔瓦窦。总共有14名患者患有A型,7名患者患有B型,8名患者患有C型,4名患者患有源自左瓦尔萨尔瓦窦的D型异常右冠状动脉。13名患者使用Tiger导管完成冠状动脉造影,8名患者使用Judkins左JL,1名患者使用额外备份(XB3)。在经皮冠状动脉介入治疗组中,分别有5名、2名和1名患者使用Judkins left(JL)、Amplatz left(AL)和XB插管,5名A型患者中,4名使用JL插管,1名使用XB插管;一个B型,带JL4;和两个具有AL2的C型。冠状动脉造影和经皮冠状动脉介入治疗的平均荧光透视时间和造影剂体积消耗分别为9.9分钟和47分钟,分别为63毫升和229毫升。结论:左瓦尔萨尔瓦窦右冠状动脉异常的冠状动脉介入治疗由于导管选择不当而困难,并且与较高的平均荧光透视时间和造影剂体积有关。径向路径对于成功的手术同样有效。
{"title":"Coronary Angiography and Percutaneous coronary Intervention in Anomalous Origin of Right Coronary Artery Arising from the Left Sinus of Valsalva","authors":"C. Poudel, R. Gajurel, H. Shrestha, S. Devkota, S. Thapa, R. Khanal, S. Shakya, B. Manandhar, V. Yadav","doi":"10.3126/njh.v20i2.48952","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48952","url":null,"abstract":"Background and Aims: To assess the difficulties encountered while performing coronary angiography and percutaneous coronary intervention in anomalous right coronary artery arising from the left sinus of Valsalva. \u0000Methods: Between January 2016 and December 2020, a total of 23 patients underwent coronary angiography and eight underwent percutaneous coronary intervention for an angiographic significant lesion in the anomalous right coronary artery arising from the left sinus of Valsalva. The vascular approach, usage of catheters, fluoroscopic time, and the amount of contrast used were also assessed. \u0000Results: Among 6000 coronary angiography and 1500 percutaneous coronary intervention performed, 33 patients (0.55%) had right coronary artery arising from the left sinus of Valsalva. Altogether, 14 patients had type-A, seven had Type-B, eight had Type-C, and four had Type-D anomalous right coronary artery arising from the left sinus of Valsalva. Coronary Angiography was accomplished with the Tiger catheter in 13 patients, Judkins left JL in 8 patients, and Extra-backup (XB3) in one patient. In the percutaneous coronary intervention group, cannulation was done with Judkins left (JL), Amplatz left (AL), and XB in five, two, and one patient respectively and among five type-A patients, four were cannulated with JL and one with XB; one Type-B with JL4; and two Type-C with AL2. The mean fluoroscopic time and contrast volume consumption for coronary angiography and percutaneous coronary intervention were 9.9 minutes and 47 minutes respectively and 63ml and 229 ml respectively. \u0000Conclusion: Coronary intervention of anomalous right coronary artery arising from the left sinus of Valsalva is difficult due to inappropriate selection of guide catheter and is associated with a higher both mean fluoroscopic time and contrast volume. Radial route is equally effective for successful procedure.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46693178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Prediabetes in Patients with Acute Coronary Syndrome: A Descriptive Cross-Sectional Study 急性冠状动脉综合征患者糖尿病前期患病率的描述性横断面研究
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48933
B. Karki, J. Ghimire, B. Nepal, A. Mahaseth, A. Sah, Swapnil Pandit, N. Pandey, P. Shah, P. Karki
Background and Aims: Diabetes mellitus is a well recognized risk factor for cardiovascular disease and acute coronary syndrome. It is becoming increasingly clear that pre-diabetic state is also associated with adverse clinical outcomes. However, evidence is limited regarding the prognostic value of 'prediabetes' on the clinical outcome of acute coronary syndrome. So, we aimed to assess the prevalence of prediabetes in acute coronary syndrome patients and its clinical outcome Methods: This was a single center descriptive cross-sectional study to know the prevalence of prediabetes in 115 patients consisting of 71 males and 44 females, admitted with acute coronary syndrome in the Department of Cardiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal, between August 2020 to July 2021. Results: Based on the definition of 2020 American Diabetic Association, 35 (30.4%) patients were newly diagnosed diabetic, 46 (40%) patients were prediabetic and 34(29.6%) were non-diabetic. Based on HbA1c alone, 26.1% patients were classified as newly diagnosed diabetic patients, 38.3% patients were classified as prediabetic and 35.7% as non-diabetic. Compared with patients without diabetes, patients with prediabetes tended to have a longer hospital stay (p=0.04), higher creatine level (p=0.01) and higher incidence of heart failure (p=0.046). Conclusion: Prediabetes is common in patients presenting with acute coronary syndrome who are not previously known to have diabetes. Further multi-center studies with long term clinical follow-up are needed to draw a firm conclusion regarding the impact of prediabetes on clinical outcome
背景和目的:糖尿病是公认的心血管疾病和急性冠状动脉综合征的危险因素。越来越清楚的是,糖尿病前期状态也与不良临床结果有关。然而,关于“糖尿病前期”对急性冠状动脉综合征临床结果的预后价值的证据有限。因此,我们旨在评估急性冠状动脉综合征患者中糖尿病前期的患病率及其临床结果,尼泊尔,2020年8月至2021年7月。结果:根据2020年美国糖尿病协会的定义,35名(30.4%)患者是新诊断的糖尿病患者,46名(40%)患者是糖尿病前期患者,34名(29.6%)患者是非糖尿病患者。仅根据HbA1c,26.1%的患者被归类为新诊断的糖尿病患者,38.3%的患者被分类为糖尿病前期,35.7%的患者被划分为非糖尿病患者。与非糖尿病患者相比,糖尿病前期患者的住院时间更长(p=0.04),肌酸水平更高(p=0.01),心力衰竭发生率更高(p=0.046)。需要进一步的多中心研究和长期临床随访,才能就糖尿病前期对临床结果的影响得出确切的结论
{"title":"Prevalence of Prediabetes in Patients with Acute Coronary Syndrome: A Descriptive Cross-Sectional Study","authors":"B. Karki, J. Ghimire, B. Nepal, A. Mahaseth, A. Sah, Swapnil Pandit, N. Pandey, P. Shah, P. Karki","doi":"10.3126/njh.v20i2.48933","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48933","url":null,"abstract":"Background and Aims: Diabetes mellitus is a well recognized risk factor for cardiovascular disease and acute coronary syndrome. It is becoming increasingly clear that pre-diabetic state is also associated with adverse clinical outcomes. However, evidence is limited regarding the prognostic value of 'prediabetes' on the clinical outcome of acute coronary syndrome. So, we aimed to assess the prevalence of prediabetes in acute coronary syndrome patients and its clinical outcome \u0000Methods: This was a single center descriptive cross-sectional study to know the prevalence of prediabetes in 115 patients consisting of 71 males and 44 females, admitted with acute coronary syndrome in the Department of Cardiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal, between August 2020 to July 2021. \u0000Results: Based on the definition of 2020 American Diabetic Association, 35 (30.4%) patients were newly diagnosed diabetic, 46 (40%) patients were prediabetic and 34(29.6%) were non-diabetic. Based on HbA1c alone, 26.1% patients were classified as newly diagnosed diabetic patients, 38.3% patients were classified as prediabetic and 35.7% as non-diabetic. Compared with patients without diabetes, patients with prediabetes tended to have a longer hospital stay (p=0.04), higher creatine level (p=0.01) and higher incidence of heart failure (p=0.046). \u0000Conclusion: Prediabetes is common in patients presenting with acute coronary syndrome who are not previously known to have diabetes. Further multi-center studies with long term clinical follow-up are needed to draw a firm conclusion regarding the impact of prediabetes on clinical outcome","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49489198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of COVID 19 on outcome of primary percutaneous coronary intervention in Nepal. 2019冠状病毒病对尼泊尔初级经皮冠状动脉介入治疗结果的影响。
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48863
A. Kadel, S. Karki, B. Rauniyar, Sushant Kharel, K. Neupane, K. Acharya, K. Sherpa, C. Adhikari
Background and Aims: The COVID 19 pandemic have affected the patients with ST segment elevation myocardial infarction as the number of patients presenting with STEMI declined substantially and those who underwent primary PCI had poor outcome. Our aim was to analyze the in-hospital and 30-days mortality in STEMI undergoing Primary PCI during second wave of COVID 19. Methods: A prospective cohort study was conducted at Shahid Gangalal National Heart Centre, Bansbari, Kathmandu. Convenience sampling of patients who underwent primary PCI were enrolled in this study and were followed up for 30 days. Numerical variables were described as Mean ± Standard Deviation (SD) and categorical variables were described as frequency and percentage. p values were calculated and considered significant if < 0.05. Results: During this study period of 2 months from 1st May 2021 to 30th June 2021, 97 patients with STEMI underwent primary PCI, including 12 (12.47%) COVID 19 positive cases. 30 days mortality was 15.4% including in-hospital mortality of 11.34%. Among COVID 19 positive cases, in-hospital mortality was 33.33% and 30-days mortality was 55.55% which was significantly higher than non COVID 19 patient who underwent primary PCI (P=0.003). Conclusion: Overall, mortality rate of primary PCI during COVID 19 second wave has been increased and mortality of COVID 19 positive patients who underwent primary PCI was significantly higher than non-COVID 19 patients who underwent primary PCI.
背景和目的:2019冠状病毒病大流行对ST段抬高型心肌梗死患者产生了影响,STEMI患者数量大幅下降,且接受首次PCI治疗的患者预后较差。我们的目的是分析第二波COVID - 19期间接受初级PCI治疗的STEMI患者的住院死亡率和30天死亡率。方法:一项前瞻性队列研究在加德满都班斯巴里的Shahid Gangalal国家心脏中心进行。本研究纳入了方便抽样的接受首次PCI治疗的患者,随访30天。数值变量用均数±标准差(SD)表示,分类变量用频率和百分比表示。计算P值,认为P值< 0.05显著。结果:在2021年5月1日至2021年6月30日的2个月研究期间,97例STEMI患者接受了原发性PCI治疗,其中12例(12.47%)呈COVID - 19阳性。30天死亡率为15.4%,其中住院死亡率为11.34%。COVID - 19阳性患者住院死亡率为33.33%,30天死亡率为55.55%,显著高于非COVID - 19患者行首次PCI (P=0.003)。结论:总体而言,COVID - 19第二波期间原发性PCI的死亡率有所上升,且COVID - 19阳性患者行原发性PCI的死亡率明显高于非COVID - 19患者行原发性PCI的死亡率。
{"title":"Impact of COVID 19 on outcome of primary percutaneous coronary intervention in Nepal.","authors":"A. Kadel, S. Karki, B. Rauniyar, Sushant Kharel, K. Neupane, K. Acharya, K. Sherpa, C. Adhikari","doi":"10.3126/njh.v20i2.48863","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48863","url":null,"abstract":"Background and Aims: The COVID 19 pandemic have affected the patients with ST segment elevation myocardial infarction as the number of patients presenting with STEMI declined substantially and those who underwent primary PCI had poor outcome. Our aim was to analyze the in-hospital and 30-days mortality in STEMI undergoing Primary PCI during second wave of COVID 19. \u0000Methods: A prospective cohort study was conducted at Shahid Gangalal National Heart Centre, Bansbari, Kathmandu. Convenience sampling of patients who underwent primary PCI were enrolled in this study and were followed up for 30 days. Numerical variables were described as Mean ± Standard Deviation (SD) and categorical variables were described as frequency and percentage. p values were calculated and considered significant if < 0.05. \u0000Results: During this study period of 2 months from 1st May 2021 to 30th June 2021, 97 patients with STEMI underwent primary PCI, including 12 (12.47%) COVID 19 positive cases. 30 days mortality was 15.4% including in-hospital mortality of 11.34%. Among COVID 19 positive cases, in-hospital mortality was 33.33% and 30-days mortality was 55.55% which was significantly higher than non COVID 19 patient who underwent primary PCI (P=0.003). \u0000Conclusion: Overall, mortality rate of primary PCI during COVID 19 second wave has been increased and mortality of COVID 19 positive patients who underwent primary PCI was significantly higher than non-COVID 19 patients who underwent primary PCI.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46159115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Patient Blood Management Stewardship Campaign Nepal 尼泊尔患者血液管理管理运动
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48935
A. Amatya
Although the World Health Organization has endorsed Patient blood management (PBM) in 2010 many hospitals still seek guidance with the implementation of PBM in clinical routine. This article presents how a Himalayan country; Nepal collaborate to form a task force to develop recommendation implementing PBM in clinical practice for improved outcomes.
尽管世界卫生组织在2010年批准了患者血液管理(PBM),但许多医院仍在寻求在临床常规中实施PBM的指导。这篇文章介绍了一个喜马拉雅国家如何;尼泊尔合作成立了一个工作组,制定在临床实践中实施PBM的建议,以改善结果。
{"title":"Patient Blood Management Stewardship Campaign Nepal","authors":"A. Amatya","doi":"10.3126/njh.v20i2.48935","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48935","url":null,"abstract":"Although the World Health Organization has endorsed Patient blood management (PBM) in 2010 many hospitals still seek guidance with the implementation of PBM in clinical routine. This article presents how a Himalayan country; Nepal collaborate to form a task force to develop recommendation implementing PBM in clinical practice for improved outcomes.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42689684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Acute Decompensated Chronic Heart Failure: Furosemide vs Furosemide and Metolazone: A Cross-Sectional Comparative Study 治疗急性失代偿性慢性心力衰竭:速尿vs速尿与美唑酮:横断面比较研究
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-11-21 DOI: 10.3126/njh.v20i2.48870
U. Risal, P. Karki, P. Shah
Background: Heart failure is a leading cause of hospital admissions each year. In Nepal also the incidence of heart failure is increasing. Acute decompensated heart failure carries a poor prognosis. Most patients respond to intravenous loop diuretics but a substantial proportion of patients are resistant to them and may need additional diuretic agents like metolazone by the principle of “sequential nephron blockade”. Methods: In a hospital-based cross-sectional comparative study, we assigned 68 patients with acute decompensated chronic heart failure patients to receive furosemide at 1 mg/kg twice daily or furosemide at 1 mg/kg twice daily plus metolazone 5mg/day. The primary end-points were daily weight loss, negative water balance (difference between urine output and fluid intake) and symptomatic improvement on NYHA grading. Results: There were 55% males and 45% females in total. There was a significant difference (p-value =0.003) in mean weight loss observed between the two groups on day three, i.e., 0.971±0.6 kg and 1.5±0.78 kg in furosemide group and furosemide plus metolazone group respectively. Mean negative water significantly more in the combination group on day two (450±230.94 ml vs 750.59±416.92 ml) with p-value <0.001 and day three (780.88±352.48 ml vs 504.38±292.46 ml) with p-value 0.001. There was no significant change in symptoms on the basis of NYHA grading between the two groups, duration of hospital stay and adverse events like hypotension, acute kidney injury and dyselectrolytemia. Conclusion: Among patients with acute decompensated chronic heart failure, treatment with combination of furosemide and metolazone was found to be more effective than furosemide alone without significant increase in adverse effects.
背景:心力衰竭是每年住院的主要原因。在尼泊尔,心力衰竭的发病率也在增加。急性失代偿性心力衰竭预后不良。大多数患者对静脉循环利尿剂有反应,但有相当一部分患者对它们有耐药性,可能需要根据“序贯肾元阻断”原则使用额外的利尿剂,如美托酮。方法:在一项以医院为基础的横断比较研究中,我们将68例急性失代偿性慢性心力衰竭患者分配给1 mg/kg每日2次的呋塞米或1 mg/kg每日2次的呋塞米加5mg/天的美唑酮。主要终点是每日体重减轻,负水分平衡(尿量和液体摄入量之间的差异)和NYHA分级的症状改善。结果:男性占55%,女性占45%。第3天,两组患者平均体重减轻量分别为0.971±0.6 kg、1.5±0.78 kg,差异有统计学意义(p值=0.003)。联合用药组第2天(450±230.94 ml vs 750.59±416.92 ml)平均负水明显增多,p值<0.001;第3天(780.88±352.48 ml vs 504.38±292.46 ml)平均负水明显增多,p值<0.001。两组患者在NYHA评分、住院时间、低血压、急性肾损伤、电解质障碍等不良事件的基础上,症状无明显变化。结论:在急性失代偿性慢性心力衰竭患者中,呋塞米联合美唑酮治疗效果优于单用呋塞米,且不良反应无明显增加。
{"title":"Treatment of Acute Decompensated Chronic Heart Failure: Furosemide vs Furosemide and Metolazone: A Cross-Sectional Comparative Study","authors":"U. Risal, P. Karki, P. Shah","doi":"10.3126/njh.v20i2.48870","DOIUrl":"https://doi.org/10.3126/njh.v20i2.48870","url":null,"abstract":"Background: Heart failure is a leading cause of hospital admissions each year. In Nepal also the incidence of heart failure is increasing. Acute decompensated heart failure carries a poor prognosis. Most patients respond to intravenous loop diuretics but a substantial proportion of patients are resistant to them and may need additional diuretic agents like metolazone by the principle of “sequential nephron blockade”. \u0000Methods: In a hospital-based cross-sectional comparative study, we assigned 68 patients with acute decompensated chronic heart failure patients to receive furosemide at 1 mg/kg twice daily or furosemide at 1 mg/kg twice daily plus metolazone 5mg/day. The primary end-points were daily weight loss, negative water balance (difference between urine output and fluid intake) and symptomatic improvement on NYHA grading. \u0000Results: There were 55% males and 45% females in total. There was a significant difference (p-value =0.003) in mean weight loss observed between the two groups on day three, i.e., 0.971±0.6 kg and 1.5±0.78 kg in furosemide group and furosemide plus metolazone group respectively. Mean negative water significantly more in the combination group on day two (450±230.94 ml vs 750.59±416.92 ml) with p-value <0.001 and day three (780.88±352.48 ml vs 504.38±292.46 ml) with p-value 0.001. There was no significant change in symptoms on the basis of NYHA grading between the two groups, duration of hospital stay and adverse events like hypotension, acute kidney injury and dyselectrolytemia. \u0000Conclusion: Among patients with acute decompensated chronic heart failure, treatment with combination of furosemide and metolazone was found to be more effective than furosemide alone without significant increase in adverse effects.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43089092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication Adherence in Post Myocardial Infarction Patients at Shahid Gangalal National Heart Centre Shahid Gangalal国家心脏中心心肌梗死后患者的药物依从性
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-05-29 DOI: 10.3126/njh.v19i1.45281
Madhu S. Giri, R. Shakya, D. Bista, Aastha Manandhar, Dikshya Giri
Background and Aims: Medication adherence among Post myocardial infarction (MI) patient is suboptimal all over the world. Although significant advances have been made in the diagnosis and management of Acute Myocardial Infraction, it is still a major cause of morbidity and mortality worldwide and significant therapeutic challenges to the society. The purpose of the study was to study the medication adherence and to identify the effect of adverse drug reaction (ADR) on medication adherence. Methods: The study was a single center, prospective study carried out in Shahid Gangalal National Heart Centre (SGNHC) in Nepal. The enrolled patients were followed up at 6th weeks after discharge in outpatient department (OPD) visit. Patients were interviewed with Morisky Green Levine (MGL) adherence scale questionnaire to identify medication adherence. The ADR was assessed. Data were analyzed in SPSS version 20. Results: A total of 134 patients were included in the study. The study showed post MI patient were highly adherent to medication (92.5%). ADR was not significantly associated with medication adherence. Conclusion: Patients were highly adherent to medication and the effect of ADR on medication adherence was not significant.
背景和目的:心肌梗死后患者的药物依从性在世界各地都不理想。尽管在急性心肌梗死的诊断和治疗方面取得了重大进展,但它仍然是全球发病率和死亡率的主要原因,也是社会面临的重大治疗挑战。本研究的目的是研究药物依从性,并确定药物不良反应(ADR)对药物依从性的影响。方法:该研究是在尼泊尔Shahid Gangalal国家心脏中心(SGNHC)进行的一项单中心前瞻性研究。入选患者在出院后第6周在门诊部(OPD)就诊时进行随访。采用Morisky Green Levine(MGL)依从性量表对患者进行访谈,以确定药物依从性。对ADR进行了评估。数据在SPSS版本20中进行分析。结果:共有134名患者被纳入研究。研究表明,MI后患者对药物的依从性很高(92.5%),ADR与药物依从性无显著相关性。结论:患者对药物的依从性较高,ADR对药物依从性的影响不显著。
{"title":"Medication Adherence in Post Myocardial Infarction Patients at Shahid Gangalal National Heart Centre","authors":"Madhu S. Giri, R. Shakya, D. Bista, Aastha Manandhar, Dikshya Giri","doi":"10.3126/njh.v19i1.45281","DOIUrl":"https://doi.org/10.3126/njh.v19i1.45281","url":null,"abstract":"Background and Aims: Medication adherence among Post myocardial infarction (MI) patient is suboptimal all over the world. Although significant advances have been made in the diagnosis and management of Acute Myocardial Infraction, it is still a major cause of morbidity and mortality worldwide and significant therapeutic challenges to the society. The purpose of the study was to study the medication adherence and to identify the effect of adverse drug reaction (ADR) on medication adherence. \u0000Methods: The study was a single center, prospective study carried out in Shahid Gangalal National Heart Centre (SGNHC) in Nepal. The enrolled patients were followed up at 6th weeks after discharge in outpatient department (OPD) visit. Patients were interviewed with Morisky Green Levine (MGL) adherence scale questionnaire to identify medication adherence. The ADR was assessed. Data were analyzed in SPSS version 20. \u0000Results: A total of 134 patients were included in the study. The study showed post MI patient were highly adherent to medication (92.5%). ADR was not significantly associated with medication adherence. \u0000Conclusion: Patients were highly adherent to medication and the effect of ADR on medication adherence was not significant.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43535636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Society of Nepal (CSN) and World Heart Federation (WHF) Cardiovascular Diseases Scorecard Project 尼泊尔心脏学会(CSN)和世界心脏联合会(WHF)心血管疾病记分卡项目
IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-05-29 DOI: 10.3126/njh.v19i1.45327
D. Prajapati, Bijoy G Rajbanshi, C. Adhikari, D. Sharma
Cardiac Society of Nepal in coordination with World Heart Federation created this scorecard or Cardiovascular profile for identification of different markers for the incidence and prevalence of heart disease in Nepal. The objective of the scorecard was to understand and assess national CVD action from a civil society perspective in an effort to complement and support official government surveillance, monitoring and reporting on CVD.
尼泊尔心脏学会与世界心脏联合会合作创建了该记分卡或心血管概况,用于识别尼泊尔心脏病发病率和患病率的不同标志物。记分卡的目的是从民间社会的角度了解和评估国家心血管疾病行动,以补充和支持政府对心血管疾病的官方监督、监测和报告。
{"title":"Cardiac Society of Nepal (CSN) and World Heart Federation (WHF) Cardiovascular Diseases Scorecard Project","authors":"D. Prajapati, Bijoy G Rajbanshi, C. Adhikari, D. Sharma","doi":"10.3126/njh.v19i1.45327","DOIUrl":"https://doi.org/10.3126/njh.v19i1.45327","url":null,"abstract":"Cardiac Society of Nepal in coordination with World Heart Federation created this scorecard or Cardiovascular profile for identification of different markers for the incidence and prevalence of heart disease in Nepal. The objective of the scorecard was to understand and assess national CVD action from a civil society perspective in an effort to complement and support official government surveillance, monitoring and reporting on CVD.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46349486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Nepalese Heart Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1